Biological Products, (No Diagnostic Substances) · CIK 1907108
Develops gene therapies for genetic cardiovascular diseases using AAV vectors
Comparable business profile · signals at a glance
In the 90 days to Feb 18, 2026: 2 sold $84K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 18, 2026 | Townsend Richard NolanChief Executive Officer | Sell | 10,173 | $6.38 | $65K |
| Feb 18, 2026 | Otero Jose ManuelChief Operating Officer | Sell | 3,016 | $6.40 | $19K |
| Nov 18, 2025 | Townsend Richard NolanChief Executive Officer | Sell | 1,127 | $9.27 | $10K |
| Nov 18, 2025 | Otero Jose ManuelChief Operating Officer | Sell | 721 | $9.27 | $7K |
| Nov 18, 2025 | Adler EricChief Medical Officer | Sell | 615 | $9.27 | $6K |
| Nov 18, 2025 | Robertson JennyChief Legal Officer | Sell | 549 | $9.27 | $5K |
| Nov 18, 2025 | See Tai SandiChief Development Officer | Sell | 386 | $9.27 | $4K |
| Oct 17, 2025 | Townsend Richard NolanChief Executive Officer | Sell | 12,985 | $8.94 | $116K |
| Oct 17, 2025 | See Tai SandiChief Development Officer | Sell | 3,844 | $8.94 | $34K |
| Oct 17, 2025 | Robertson JennyChief Legal Officer | Sell | 3,486 | $8.94 | $31K |
| Oct 17, 2025 | Adler EricChief Medical Officer | Sell | 3,344 | $8.94 | $30K |
| Oct 17, 2025 | Otero Jose ManuelChief Technical Officer | Sell | 2,091 | $8.94 | $19K |
| Oct 17, 2025 | Townsend Richard NolanChief Executive Officer | Sell | 148 | $9.56 | $1K |
| Oct 17, 2025 | See Tai SandiChief Development Officer | Sell | 44 | $9.56 | $421 |
| Oct 17, 2025 | Robertson JennyChief Legal Officer | Sell | 40 | $9.56 | $382 |
| Oct 17, 2025 | Adler EricChief Medical Officer | Sell | 38 | $9.56 | $363 |
| Oct 17, 2025 | Otero Jose ManuelChief Technical Officer | Sell | 24 | $9.56 | $229 |
| Aug 18, 2025 | Otero Jose ManuelChief Technical Officer | Sell | 721 | $9.27 | $7K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.